Radiotherapy
10 videos · last 6 months shuffled daily, then older videos newest first
▶
36:39 Clinical Trials: Prostate Cancer + New Nuclear Medicines
Katie Clift talks to Simone Leyden AM of Telix Pharmaceuticals about how clinical trials are shaping nuclear medicine for prostate cancer, and why patient participation in research matters.
▶
3:35 Oncology Bytes: Dr Piyush Aggarwal on the Lu-PRIME Phase II Trial
Dr Piyush Aggarwal of PGIMER Chandigarh presents preliminary results from Lu-PRIME, a Phase II trial of 177Lu-PSMA-617 primed with enzalutamide in 20 men with metastatic castration-resistant prostate cancer.
▶
1:46 Local Consolidative Therapy with Osimertinib: NorthStar Trial Background and Secondary Analysis
Saumil Ghandi, MD, PhD, of MD Anderson on the rationale and secondary analysis of the NorthStar trial, which added radiation or surgery alongside continued osimertinib.
▶
58:33 A Practical Guide to Imaging in Radiopharmaceutical Trials
Eric Frey of Radiopharmaceutical Imaging and Dosimetry and Jarrod Longcor of Cellectar Biosciences join Image Analysis Group to discuss dosimetry, quantitative imaging and multicenter operations in radiopharmaceutical trials.
▶
2:33 The ROSALIE Clinical Trial - Breast Cancer Trials
The ROSALIE trial is testing whether patients can safely skip radiotherapy when no cancer remains in the breast after chemotherapy and surgery.
▶
2:29 The PROSPECTIVE Clinical Trial - Monica Kelly
Monica Kelly is a participant in the PROSPECTIVE trial, which is testing whether surgery without radiotherapy still stops breast cancer coming back.
▶
29:22 Radiotheranostics in Prostate Cancer: Dr. Johannes Czernin
Dr. Johannes Czernin reviews the prostate cancer trials behind FDA approvals of radiotheranostics, ongoing phase 3 trials that would move them earlier in treatment, and supply, access and the business case.
▶
7:48 Focus RT Prostate Cancer Trial: Participant FAQs
The National Cancer Institute answers prospective participants' questions about the Center for Cancer Research's Focus RT prostate cancer trial (NCT05616650), led by Krishnan R. Patel, M.D., of the Radiation Oncology Branch.
▶
20:53 The Future of Targeted Radiopharmaceutical Therapy in Prostate Cancer
Katie Clift hosts a session on the ProstACT GLOBAL study, how TLX591 differs from existing treatments, and recruitment across 12 Telix trial sites in Australia and New Zealand.
▶
7:24 Gaps and Hurdles in Phase 2 Radioligand Therapy Trials
Delphine Chen, MD, of Fred Hutch Cancer Center, reviews ongoing Phase 2 radiopharmaceutical therapy trials, the regulatory and logistical hurdles they face moving to Phase 3, and gaps such as tumour type, at SNMMI 2025, for GU Oncology Now.